The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 19, 2026

Filed:

Jan. 25, 2023
Applicant:

Bausch + Lomb Ireland Limited, Dublin, IE;

Inventors:

Alok Kumar Awasthi, Pittsford, NY (US);

Feng-Yang Shih, Rochester, NY (US);

Mohammad Vatankhah Varnosfaderani, Rochester, NY (US);

James Anthony Dibella, Jr., Macedon, NY (US);

Mark R. Mis, Rush, NY (US);

Jade J. Russell, Perry, NY (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G02B 1/04 (2006.01); G02C 7/04 (2006.01);
U.S. Cl.
CPC ...
G02B 1/043 (2013.01); G02C 7/04 (2013.01);
Abstract

A multifunctional crosslinking agent includes one or more repeating units of a siloxanyl group or a silyl-alkyl-siloxanyl group, and at least two ethylenically unsaturated reactive end groups. One of the at least two ethylenically unsaturated reactive end groups is a (meth)acrylate-containing reactive end group or an acrylamide-containing reactive end group and the other one is an allyl-containing reactive end group or a vinyl-containing reactive end group. Ophthalmic devices are formed from a polymerization product of a monomeric mixture containing one or more of the multifunctional crosslinking agents, one or more first ophthalmic device-forming comonomers having at least one reactive group that preferentially reacts with the (meth)acrylate-containing reactive end group or the acrylamide-containing reactive end group of the multifunctional crosslinking agent, and one or more second ophthalmic device-forming comonomers having at least one reactive group that preferentially reacts with the allyl-containing reactive end group or the vinyl-containing reactive end group of the multifunctional crosslinking agent.


Find Patent Forward Citations

Loading…